Appendix 4D Half Yearly Report
Filed with ASX · · 22 pages · English
CLINUVEL Profitability since Launch of Commercial Operations, Half Yearly, A$m Revenues Other CLINUVEL Group Collins Square, Tower 5 727 Collins Street Melbourne Victoria 3008 Correspondence to: GPO Box 4736 Melbourne Victoria 3001 Independent Auditor’s Review Report T +61 3 8320 2222 F +61 3 8320 2200 E info.vic@au.gt.com W www.grantthornton.com.au Report on the review of the half-year financial
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- CLINUVEL Strategic Update - Extended
- Media Release - CLINUVEL to Trial Innovative Drug in Stroke
- Australian TGA approves SCENESSE
- Trading Halt
- Media Release - First patient dosed in SCENESSE DNA Repair
Later from Clinuvel Pharmaceuticals
- Media Release - CLINUVEL expands DNA Repair Program
- Appendix 4C - quarterly
- Appendix 4E and Preliminary Financial Report
- CLINUVEL Delivers Record Revenues and Profit
- Response to ASX Price Query
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals